Research shows that postmenopausal women have a 22% higher probability of developing fatty liver disease compared to premenopausal women, according to a Gram Research analysis of 15,106 Korean women. This association remained significant even after accounting for weight and other metabolic factors, with the strongest connection appearing in women in their early 40s. The findings suggest that metabolic screening becomes especially important as women enter menopause.
A large study of over 15,000 Korean women found that menopause significantly increases the risk of developing fatty liver disease, a condition where fat builds up in liver cells. Researchers discovered that postmenopausal women were 22% more likely to have signs of this disease compared to women still having periods. The connection was strongest in women in their early 40s and weakened as women got older. This research suggests that women entering menopause should pay special attention to their metabolic health through screening and lifestyle changes.
Key Statistics
A 2026 cross-sectional study of 15,106 Korean women found that postmenopausal women had a 22% higher probability of fatty liver disease compared to premenopausal women, even after adjusting for age, weight, and metabolic risk factors.
Among 15,106 middle-aged Korean women studied from 2007-2023, 31.5% were postmenopausal and 22.1% met criteria for fatty liver disease probability, with postmenopausal status independently associated with increased disease risk.
The association between menopause and fatty liver disease was strongest in women aged 40-49 years and progressively weakened in older age groups, according to a 2026 analysis of national health survey data from over 15,000 women.
The Quick Take
- What they studied: Whether menopause increases the chances of developing fatty liver disease in middle-aged women
- Who participated: 15,106 Korean women aged 40 to 59 years who participated in a national health survey between 2007 and 2023
- Key finding: Postmenopausal women had a 22% higher probability of fatty liver disease compared to premenopausal women, even after accounting for weight, age, and other health factors
- What it means for you: If you’re entering menopause, talking to your doctor about liver health screening and metabolic risk factors becomes more important. However, this study shows association, not that menopause directly causes the disease—other factors still play major roles
The Research Details
Researchers analyzed health information from over 15,000 Korean women collected over 16 years (2007-2023) as part of a national health survey. They compared women who had gone through menopause with women who hadn’t, looking at whether they showed signs of fatty liver disease. The study used a special calculation called the hepatic steatosis index to identify fatty liver, combined with checking for metabolic problems like high blood sugar or abnormal cholesterol.
The researchers carefully adjusted their analysis to account for factors that could affect the results, including age, body weight, waist size, and metabolic risk factors. They also looked at whether the menopause-liver disease connection was stronger or weaker depending on a woman’s age group, finding that the relationship changed across different age ranges.
This approach is important because it uses real-world data from a large, representative population rather than a controlled lab setting. By studying actual women over many years, researchers can see patterns that reflect what happens in everyday life. The study’s size and diversity make the findings more reliable than smaller studies.
This is a cross-sectional study, meaning it captures a snapshot in time rather than following women forward. This type of study can show associations but cannot prove that menopause directly causes fatty liver disease. The study’s strengths include its large sample size, use of standardized health measurements, and adjustment for multiple confounding factors. Limitations include reliance on self-reported menopause status and inability to establish cause-and-effect relationships.
What the Results Show
Among the 15,106 women studied, about 31.5% had gone through menopause. Approximately 22.1% of all women showed signs of fatty liver disease. Postmenopausal women had significantly higher rates of metabolic problems, including higher blood pressure, blood sugar issues, and abnormal cholesterol levels compared to premenopausal women.
When researchers statistically controlled for weight, age, and metabolic risk factors, postmenopausal women still showed a 22% higher probability of having fatty liver disease. This means the menopause connection remained even after accounting for other factors that could explain the difference.
The strength of this association varied by age group. Women in their early 40s who had gone through menopause showed the strongest connection to fatty liver disease. As women got older (into their 50s), the relationship between menopause and fatty liver disease became weaker, suggesting that age itself becomes a more important factor than menopause status.
The study revealed that postmenopausal women had worse overall metabolic health profiles, including higher rates of obesity, elevated blood pressure, and abnormal blood sugar levels. These metabolic problems themselves are major risk factors for fatty liver disease, which helps explain why postmenopausal women are at higher risk.
According to Gram Research analysis, this study adds important evidence to a growing body of research showing that menopause affects liver health. Previous studies suggested hormonal changes during menopause might increase disease risk, but this is one of the first large population studies to confirm this connection using updated diagnostic criteria that emphasize metabolic dysfunction as the key driver of fatty liver disease.
This study shows association but cannot prove menopause causes fatty liver disease—other unmeasured factors could explain the connection. The study relied on women reporting their own menopause status rather than medical records, which could introduce errors. Additionally, the study included only Korean women, so findings may not apply equally to other populations. The cross-sectional design means researchers captured only one moment in time for each woman, not how their health changed over years.
The Bottom Line
Women approaching or in early menopause should discuss metabolic screening with their healthcare provider, including liver function tests and metabolic panels. Maintaining healthy weight, regular physical activity, and managing blood sugar and cholesterol become especially important during this life stage. These recommendations have moderate confidence based on this research combined with existing evidence about metabolic health.
Women aged 40-55 should pay particular attention to these findings, as the menopause-liver disease connection is strongest in this age group. Women with existing metabolic problems (obesity, diabetes, high cholesterol) should be especially proactive. Men and postmenopausal women over 60 may benefit from general metabolic screening but face lower relative risk from menopause-related changes.
Fatty liver disease typically develops gradually over months to years. Lifestyle changes like weight management and increased exercise can show benefits within 3-6 months, though significant improvements in liver health may take 6-12 months of consistent effort.
Frequently Asked Questions
Does menopause cause fatty liver disease?
Menopause is associated with higher fatty liver disease risk, but doesn’t directly cause it. Hormonal changes during menopause worsen metabolic health—including weight gain and blood sugar problems—which are the actual drivers of fatty liver disease.
What age should women start screening for fatty liver disease?
Women entering menopause (typically early 40s) should discuss liver health screening with their doctor, especially if they have metabolic risk factors like obesity, high blood pressure, or diabetes. The research shows risk is highest in women aged 40-49.
Can lifestyle changes prevent fatty liver disease during menopause?
Yes. Maintaining healthy weight, exercising regularly (150 minutes weekly), reducing added sugars, and managing blood pressure and cholesterol can significantly reduce fatty liver disease risk. These changes are particularly important during menopause when metabolic changes accelerate.
Is fatty liver disease dangerous?
Fatty liver disease can progress to serious liver damage if untreated, but early detection and lifestyle changes can prevent progression. Most people with fatty liver disease have no symptoms, making screening important for at-risk groups like menopausal women.
Want to Apply This Research?
- Track waist circumference monthly and blood pressure weekly, as these are key metabolic markers linked to fatty liver disease risk. Set a reminder for annual liver function blood tests starting at age 40.
- Log daily physical activity (aim for 150 minutes moderate exercise weekly) and monitor dietary choices, particularly reducing added sugars and processed foods, which are linked to fatty liver disease.
- Create a metabolic health dashboard tracking weight, waist circumference, blood pressure, and scheduled lab work. Set quarterly check-ins to review trends and adjust lifestyle goals with healthcare provider input.
This research shows an association between menopause and fatty liver disease but does not prove menopause causes the disease. Individual risk varies based on genetics, lifestyle, and other health factors. This information is for educational purposes and should not replace professional medical advice. Consult your healthcare provider about appropriate screening and management strategies for your individual situation, especially if you have risk factors for metabolic disease or liver problems.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.